According to OncoCyte 's latest financial reports the company's current EPS (TTM) is -$10.27. In 2022 the company made an earnings per share (EPS) of -$13.28 an increase over its 2021 EPS that were of -$14.20.
Year | EPS | Change |
---|---|---|
2023 (TTM) | -$10.27 | -22.67% |
2022 | -$13.28 | -6.48% |
2021 | -$14.20 | 54.35% |
2020 | -$9.20 | 6.98% |
2019 | -$8.60 | 2.38% |
2018 | -$8.40 | -34.38% |
2017 | -$12.80 | 48.84% |
2016 | -$8.60 | -35.18% |
2015 | -$13.27 |